TY - JOUR
T1 - A suPAR biomarker for chronic kidney disease
AU - Skorecki, Karl L.
AU - Freedman, Barry I.
PY - 2015/11/12
Y1 - 2015/11/12
N2 - The worldwide epidemic of chronic kidney disease — an insidious illness that manifests with asymptomatic reductions in the estimated glomerular filtration rate (eGFR) to less than 60 ml per minute per 1.73 m2 of body-surface area, excessive urinary excretion of protein, or both — afflicts an estimated 600 million people.1 Many will have progression to end-stage kidney disease and require dialysis or kidney transplantation for survival or succumb to related cardiovascular complications, even while taking antihypertensive agents and medications to lower blood glucose levels.2,3 Chronic kidney disease shortens survival, reduces the quality of life remaining to these patients, and . . .
AB - The worldwide epidemic of chronic kidney disease — an insidious illness that manifests with asymptomatic reductions in the estimated glomerular filtration rate (eGFR) to less than 60 ml per minute per 1.73 m2 of body-surface area, excessive urinary excretion of protein, or both — afflicts an estimated 600 million people.1 Many will have progression to end-stage kidney disease and require dialysis or kidney transplantation for survival or succumb to related cardiovascular complications, even while taking antihypertensive agents and medications to lower blood glucose levels.2,3 Chronic kidney disease shortens survival, reduces the quality of life remaining to these patients, and . . .
UR - http://www.scopus.com/inward/record.url?scp=84946888247&partnerID=8YFLogxK
U2 - 10.1056/nejme1512997
DO - 10.1056/nejme1512997
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???
C2 - 26539740
AN - SCOPUS:84946888247
SN - 0028-4793
VL - 373
SP - 1971
EP - 1972
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 20
ER -